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Tripartite motif (TRIM) proteins are involved in various cellular functions and constitute 
key factors of the antiviral innate immune response. TRIM proteins can bind viral particles 
directly, sending them to degradation by the proteasome, or ubiquitinate signaling mol-
ecules leading to upregulation of innate immunity. TRIM proteins are present in across 
metazoans but are particularly numerous in vertebrates where genes comprising a B30.2 
domain have been often duplicated. In fish, a TRIM subset named finTRIM is highly diver-
sified, with large gene numbers and clear signatures of positive selection in the B30.2 
domain suggesting they may be involved in antiviral mechanisms. finTRIM provides a 
beautiful model to investigate the primordial implication of B30.2 TRIM subsets in the 
arsenal of vertebrate antiviral defenses. We show here that ftr83, a zebrafish fintrim gene 
mainly expressed in the gills, skin and pharynx, encodes a protein affording a potent 
antiviral activity. In vitro, overexpression of FTR83, but not of its close relative FTR82, 
induced IFN and IFN-stimulated gene expression and afforded protection against different 
enveloped and non-enveloped RNA viruses. The kinetics of IFN induction paralleled the 
development of the antiviral activity, which was abolished by a dominant negative IRF3 
mutant. In the context of a viral infection, FTR83 potentiated the IFN response. Expression 
of chimeric proteins in which the B30.2 domain of FTR83 and the non-protective FTR82 
had been exchanged, showed that IFN upregulation and antiviral activity requires both 
the Ring/BBox/Coiled coil domain (supporting E3 ubiquitin ligase) and the B30.2 domain 
of FTR83. Finally, loss of function experiments in zebrafish embryos confirms that ftr83 
mediates antiviral activity in vivo. Our results show that a member of the largest TRIM 
subset observed in fish upregulates type I IFN response and afford protection against 
viral infections, supporting that TRIMs are key antiviral factors across vertebrates.
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inTrODUcTiOn
Upon pathogen invasion, host immune response starts with detection of microbial products by pat-
tern recognition receptor (PRR), leading to cell activation and synthesis of inflammatory cytokines. 
The innate immune response to viruses involves several dedicated toll-like receptors (TLR) and 
RIGI-like receptors, which trigger two main signaling pathways—IKKα/β-NFkB and IKKε/
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TBK1-IRF3/7—and the synthesis of type I IFN (1). Type I IFN 
can function in a paracrine or autocrine manner; upon binding to 
their receptor at the cell surface, signal transduction through the 
Jak/STAT pathway leads to the formation of the ISGF3 complex 
[reviewed in Ref. (2)]. ISGF3 then translocates to the nucleus 
and promotes the expression of many effector interferon induced 
genes (ISG), some of which have antiviral activity. This virus-
induced response is tightly regulated by multiple mechanisms, 
including positive and negative feedback loops mediated by 
ISG. In contrast, other antiviral factors can be intrinsically 
expressed like APOBEC3G and TRIM5α (3), interfering at dif-
ferent steps of the virus cycle.
Many tripartite motif (TRIM) proteins are important antiviral 
factors involved in antiviral defense via multiple mechanisms: as 
direct effectors often induced by type I IFN, or as modulators/
enhancers of the response (4). TRIM proteins are defined by 
their Ring/BBox/Coiled coil (RBCC) TRIM. The really interest-
ing new gene (RING) domain has an E3 ligase activity promot-
ing conjugation of Ub or Ub-like residues such as SUMO and 
ISG15 to target proteins (5); BBox is another type of Cys-based 
motif, and Coil-coiled domains are involved in TRIM proteins 
homo-dimerization or oligomerization into large complexes (6). 
The RBCC motif is generally followed by a C-terminal domain, 
which is highly variable and determines subcellular localization, 
interactions with other proteins and cellular functions of the 
protein. For example, the B30.2 domain—also known as “PRY-
SPRY” domain (7), is found in many TRIM with antiviral func-
tions including TRIM5, TRIM21, TRIM22, and TRIM25. This 
domain constitutes a versatile scaffold promoting the assembly 
of protein complexes (8, 9) and may also have RNA binding 
properties (10).
Tripartite motif can be involved in direct antiviral mechanisms, 
in control of viral gene transcription, or in the regulation of the 
innate immune response. TRIM5α is one of the best-studied 
members of the family with a direct antiviral activity, triggered 
by B30.2 binding to HIV1 capsid shortly after virus entry into 
the cell (11). TRIM5α oligomers thus cover the viral capsid, and 
the complex is degraded by the proteasome through a process 
dependent of TRIM5α auto-ubiquitination (12). In addition, 
TRIM5α is a potent modulator of antiviral innate immunity 
(13). TRIM22 is another protein exerting its antiviral activity 
through direct interaction with proteins from different viruses, 
blocking their trafficking and promoting their degradation via 
ubiquitination (14, 15). B30.2 domains of TRIM5 and TRIM22 
evolved under strong positive selection, underlining the impor-
tance of this domain as a specific recognition module check 
(16). TRIM21 also acts through a direct mechanism, targeting 
non-enveloped antibody-opsonized virus in the cell cytoplasm, 
and sending them to degradation by the proteasome (17). The 
recognition of intracytoplasmic antibodies bound to pathogens 
by TRIM21 B30.2 domain also induces innate immune response 
and cytokine production (18). Alternatively, TRIM with a 
bromodomain target histones and mediate chromatin remod-
eling; TRIM28 thus plays an important role in the silencing of 
retrovirus genes (19). Finally, TRIM can also play an indirect role 
in antiviral immunity by modulating immune signaling, mostly 
via ubiquitination of key factors of these pathways. The best 
characterized of these mechanisms is probably the ubiquitination 
of the RNA sensor RIG-I by TRIM25, leading to the formation of 
the MAVS/RIG-I complex and IFN synthesis, and PML/TRIM19 
of which one isoform regulates IFN synthesis (20). Importantly, 
many TRIMs have the capacity of enhancing the innate immune 
response, through multiple mechanisms: a recent screen showed 
that about half of all human TRIM proteins affect these signaling 
pathways (21).
In addition to antiviral immunity, TRIM proteins exert a wide 
range of cellular functions: as modulators of gene transcription 
or factors of post-translational modifications via their E3 ligase 
activity, they are implicated in gene expression, apoptosis, cell 
proliferation and differentiation, cancer, inflammation and auto-
immune diseases, etc. (6, 22). TRIMs involved in basic cellular 
functions often belong to the most ancient subsets, e.g., RBCC-
Cos-Fn3-B30.2 TRIM, which were already present in early meta-
zoans (23) and are found both in vertebrates and invertebrates 
(24). Only a few trim genes are generally present in the genome 
of invertebrates, while the family greatly expanded in vertebrates. 
Trim genes with an RBCC-B30.2 domain organization were 
particularly prone to amplification (25, 26), and large sets of such 
genes arose from independent expansions in fish, coelacanth, and 
tetrapods (25–27). The implication of TRIM in antiviral defense 
likely was a strong selection pressure toward diversification, but 
the antiviral functions of these proteins in non-mammalian 
vertebrates remain poorly characterized.
Fish possess a large repertoire of TRIMs, with several large 
specific gene expansions including finTRIMs (28), bloodthirsty-
related TRIM (TRIM39) and TRIM35 (25, 26). Antiviral func-
tions have been recently reported for several TRIM proteins 
of the orange spotted grouper in in  vitro systems: TRIM8 and 
TRIM32 upregulated genes of the type I IFN system, while viral 
gene transcription was inhibited in cells overexpressing TRIM39 
(29–31). In contrast, TRIM13, TRIM16L, and TRIM62L appear 
to downregulate the antiviral immune response, promoting 
nodavirus or iridovirus infections (32–34). FinTRIMs, which 
constitute the largest TRIM expansion observed in zebrafish, 
are also likely involved in antiviral defenses. These TRIMs, 
which have an RBCC-B30.2 domain structure, were initially 
discovered in salmonids as genes induced by the rhabdovirus 
VHSV in leukocytes ex vivo (35). In the zebrafish, the B30.2 
domain of finTRIMs evolved under strong positive selection, 
at positions remarkably congruent with those identified in the 
viral recognition motif of TRIM5α in primates (28, 36). Zebrafish 
functional ftr genes are typically expressed at very low basal 
levels and weakly induced by the viral infection. Most of the 80 
ftr genes appeared recently, having no “one-to-one” orthologs 
in other fish families such as salmonids or the pufferfish family 
(26). Interestingly, two members of the family (ftr82 and ftr83) 
did not follow this pattern: they had orthologs in the main fish 
branches (28), indicating that they were likely related to the basal 
(i.e., ancestral) finTRIM genes. They were expressed at a higher 
constitutive level in multiple tissues of zebrafish larvae and were 
not induced by viral infection or IFN treatment. In this work, we 
investigated the implication of these genes in antiviral immunity. 
We show that FTR83 significantly increases basal IFN expression 
and modulates expression of ISGs, mediating a potent antiviral 
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activity against RNA viruses in  vitro and in  vivo. In contrast, 
FTR82—another FTR closely related to FTR83 but with distinct 
expression pattern, does not possess such properties. Chimeras 
between FTR82 and FTR83 showed that both FTR83 RBCC and 
B30.2 are required for antiviral functions. Our data show that 
positive regulation of the IFN pathway and antiviral functions 
are a fundamental property of finTRIMs, and more generally of 
TRIM proteins across vertebrate immune systems.
MaTerials anD MeThODs
ethics statement
All animals were handled in strict accordance with good animal 
practice as defined by the European Union guidelines for the han-
dling of laboratory animals (http://ec.europa.eu/environment/
chemicals/lab_animals/home_en.htm) and by the Regional Paris 
South Ethics committee. All animal work was approved by the 
Direction of the Veterinary Services of Versailles (authoriza-
tion number 78-28) as well as fish facilities (authorization 
number B78-720). Experimental protocols involving zebrafish 
were approved by the INRA institutional ethical committee 
“Comethea” (#12/114).
Primary antibodies
Anti-HA 3F10 monoclonal antibody was purchased from Roche 
and anti-V5 monoclonal antibody from Molecular Probes.
cloning of ftr82 and ftr83
Ftr82 (ENSDARG00000055647, transcript ENSDART00000016 
758.7), and ftr83 (ENSDARG00000025403, transcript ENSDAR 
T00000098239.4) were cloned in fusion with an HA tag, respec-
tively, in pcDNA3.3 and pcDNA3.1 (Table S1 in Supplementary 
Material). FTR chimeras were obtained by recombinant PCR 
using V5-ftr82 and ftr83-HA as templates. RBCC domains of 
ftr82 and ftr83 were, respectively, amplified with fwFTR82-Attb1/
revFTR82-B30.2ftr83 and fwFTR83-HA/revFTR83-B30.2ftr82. B30.2 
domains of ftr82 and ftr83 were, respectively, amplified with 
fwFTR83-B30.2ftr82/revHA-Ftr82, and fwFTR82-B30.2ftr83/revFTR83 
B30.2-Attb2-nostop. These PCR products were then annealed, 
and the full constructs were amplified with fwFTR82-Attb1 and 
revFTR83B30.2-Attb2-nostop for 82-83, and with fwFTR83-HA 
and revHA-Ftr82 for 83-82. 82-83 was cloned with the Gateway 
cloning system (Invitrogen) in pDSET 6.2V5 to be expressed 
with V5 tag fused to the C terminus. 83-82 was cloned with 
the TOPO TA cloning system (Invitrogen) in pcDNA3.3 to be 
expressed with HA tag fused to the N terminus. Ftr82 and ftr83 
coding regions were also amplified using primers HA-ftr83 
and ftr82-HAftr82-Attb1, ftr83-Attb1, and ftr82Attb2nostop, 
ftr83Attb2nostop (Table S1 in Supplementary Material), cloned 
into the entry vector of the Gateway cloning system (Invitrogen) 
then transferred to the different destination vectors. Ftr82 was 
transferred in pDEST6.2-V5 or pDSET 47 to be expressed with 
V5 or GFP tag fused to the C terminus. Ftr83 was transferred 
to pDEST53 to be expressed with GFP tag fused to the N ter-
minus. Ftr83 deletion mutants were obtained using specific 
primers on ftr83-HA template. Ftr83B30.2 was constructed with 
Ftr83B30.2-Attb1 and Attb-2-nostop primers while FTR83ΔB30.2 
was constructed with FTR83ΔB30.2-Attb1 and Attb2 primers 
(Table S1 in Supplementary Material). PCR products were then 
cloned using the Gateway cloning system in pDSET 47 to be 
expressed with GFP tag fused to the C terminus.
Whole Mount In Situ hybridization
Whole mount in situ hybridization was performed as described in 
Ref. (37), using NBT/BCIP revelation (Sigma). Antisense probes 
for ftr82 (product size 856 bp) and ftr83 (product size 865 bp) were 
generated with T3 polymerase (Promega). Templates for in vitro 
transcription were amplified using primers shown in Table S1 in 
Supplementary Material, and PCR products were purified using 
Microspin™ S-400 HR columns (GE Healthcare).
Fish, cells, and Viruses
Zebrafish were raised in the fish facilities of Institut National de 
la Recherche Agronomique (Jouy-en-Josas, France). Epithelioma 
papulosum cyprini (EPC) cell line (ATCC® CRL-2872™) was 
maintained in Glasgow’s modified Eagle’s medium-HEPES 
25 mM medium (Eurobio) supplemented with 10% fetal bovine 
serum (FBS, Eurobio, produced and distributed in France under 
the veterinary authorization FR 91 692 200), 1% tryptose phos-
phate broth (Eurobio), 2mM l-glutamine (PAA) and antibiotics 
100  µg/mL penicillin (Biovalley), 100  µg/mL streptomycin 
(Biovalley). Transfection experiments, viral production, and 
titration were performed in EPC cells. The novirhabdoviruses 
infectious hematopoietic necrosis virus 32-87 (IHNV) and viral 
hemorrhagic septicemia virus 07-71 (VHSV) and the vesicu-
lovirus spring viremia of carp virus (SVCV) were produced at 
14°C on EPC in GMEM media supplemented with 2% FBS, 5% 
tryptose, and 2mM l-glutamine. Cytopathic effect was evaluated 
72  h postinfection after cell fixation with 10% formol prior to 
coloration in 2% crystal violet.
Transfection
Epithelioma papulosum cyprini cells were nucleotransfected with 
the nucleofector kit T (Lonza) following the manufacturer’s rec-
ommendations. Briefly, 4 × 106 EPC cells were plated in P6 wells. 
The day after, cells were trypsinized, resuspended in 100 µL of 
nucleofector solution with 3–5 µg of DNA. After nucleotransfec-
tion, cells were resuspended in a P6 well plate for RTQPCR analy-
ses or immunocytochemistry on PDL (10  µg/mL) coated glass 
coverslips. Viral challenge was performed on P24 wells seeded 
with one million of transfected cells 24 h before viral infections.
Morpholino Knockdown experiments
Experiments were performed as described in Ref. (38). Eggs of 
wild-type AB zebrafish (one-cell stage) were microinjected with 
4  ng of morpholinos (MO) (Gene Tools): Ftr83-specific MO 
(MOftr83: TTACAACTAGACTACATACCTGTCT); Ftr82-
specific MO [MOftr82: GCGCTATGTTTTCCTTACCTGTTTT 
from Ref. (39)]; or control morpholino with no known target 
(MOctl: GAAAGCATGGCATCTGGATCATCGA). Ftr82- and 
ftr83-specific MO target splice donor sites, and efficiency of 
knockdown was assessed by qRT-PCR with splice-sensitive 
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primers (Table S1 in Supplementary Material). Embryos then 
developed with no obvious morphological defects at 28°C until 
72  hpf. Anesthetized 72 hpf larvae were challenged by intra-
venous inoculation of 100  pfu of SVCV (38) or left untreated, 
6  h postinfection, embryos were collected for gene expression 
analysis by RT-QPCR.
In Vitro infections
Ninety-six hours post transfection (hpt), EPC cell monolayers 
were infected with rhabdoviruses MOI1 by a 1 h absorption step 
at 14°C in GMEM 2% FBS. After removal of the inoculum, cells 
were incubated in GMEM 2% FBS at 14°C for the rest of the 
experiment. Cell supernatant was taken postabsorption and after 
8, 24, 48, and 72 h of infection for virus titration experiments. 
Infected cells were fixed at 72 hpi to evaluate cytopathic effect by 
crystal violet coloration. Short SVCV infections were performed 
at 72 hpt. Cells were exposed to virus inoculum (MOI1) 6 h at 
14°C before analysis of gene expression. EPC cells were also 
infected with the birnaviruses IPNV strains VR299 or 31-75, 
in GMEM media supplemented with 2% FBS, 5% tryptose, and 
2 mM l-glutamine. Cytopathic effect was evaluated 72 h postin-
fection after cell fixation with 10% formol prior to coloration in 
2% crystal violet. The birnaviruses were propagated on BF cells at 
14°C. Viruses were titrated on EPC by plaque assay as previously 
described in Ref. (40).
rna isolation, cDna synthesis
Total RNA extraction was performed by TRIZOL (Invitrogen) 
from four million EPC cells at 72 hpt or from zebrafish tissues 
sampled from 2- to 3-month-old zebrafish (strain AB). RNA 
was purified using the RNeasy mini kit (QIAGEN) according 
to the manufacturer’s instructions and treated with DNAse. 
Reverse transcription experiment was performed on 1 µg of total 
RNA using 125  ng of random hexamer primers (Roche) in a 
Superscript II Reverse transcriptase kit (Invitrogen) according to 
the manufacturer’s instructions.
real-time Q-Pcr
Gene expression was measured by real time PCR with a Realplex2 
Mastercycler Instrument (Eppendorf) using Power SYBR® Green 
PCR Mastermix (Applied Biosystems). Each sample is composed 
by 5 µL of primers (300 nM each), 5 µL of cDNA (diluted 1/10 
for cell samples and 1/5 for zebrafish samples), and 10 µL of PCR 
Mastermix. Samples were first incubated for 2 min at 50°C and for 
10 min at 95°C, then subjected to 40 amplification cycles (95°C 
for 15 and 60°C for 1 min), followed by 15 s at 95°C, 15 s at 60°C, 
20 min from 60 to 95°C and finally 15 s at 95°C, to establish the 
melting curve of PCR products. Gene expressions were com-
puted according to the ABI Prism 7700 user bulletin (Applied 
Biosystems) and normalized to the beta-actin expression level. 
All QPCR primers used in this study are shown in Table S1 in 
Supplementary Material.
immunocytochemistry
Seventy-two hours post transfection, cells were fixed in PBS pH7.4 
PFA 4% for 20 min at 4°C. After fixation, cells were permeabilized 
in 0.2% Triton X100 solution for 5 min at RT before saturation in 
PBS 2% BSA solution at RT for 1 h. Cells were then incubated with 
anti-HA (Roche) or anti-V5 (Invitrogen) monoclonal antibodies 
in PBS, 2% BSA, 0.1% Triton X100 for 1  h. Primary antibody 
binding sites were then revealed by incubation with Alexa coupled 
secondary antibodies (Molecular Probes) in PBS, 2% BSA, 0.1% 
Triton X100, and DAPI for 1 h at RT before mounting in Immuno 
Mount solution (Molecular Probes). Images were acquired on 
AxioObserver Z1 microscope (Zeiss) with a 63× Plan Neofluar 
objective using Photometrics CoolSNAP HQ2 Camera.
homology Modeling
Structural models of FTR82 and FTR83 B30.2 domains were 
built with Swiss-model program (41) using the high-resolution 
structure of mammalian TRIM25 as a template (PDB 4B8E). 
Chimera program was used for structure viewing and ftr B30.2 
superposition (42).
resUlTs
ftr82 and ftr83 are archetypal Members  
of the large Fish Multigenic ftr Family
The fintrim (ftr) family extensively diversified in parallel in each 
fish lineage (26). Among the 80 genes found in the zebrafish, tran-
scriptome studies (43) showed that, unlike most other ftr, ftr82, 
and ftr83 were well expressed constitutively in the larva, but not 
induced by IFN or viral infection (Figure S1 in Supplementary 
Material). Another feature that sets these genes apart from the 
other ftr is that they possess true orthologs in other fish species. 
Phylogenetic analysis of FTR sequences from different fish shows 
that both FTR82 and FTR83 sequences cluster in a well-supported 
group, as illustrated in Figure 1A. In contrast, other FTR clusters 
comprise sequences correspond to more recent, lineage-specific 
diversification (26). Within the conserved FTR82/83 group, 
FTR82 and FTR83 each define a specific set of orthologs; both 
ftr82 and ftr83 have an ortholog in a holostean fish, the spotted 
gar, indicating that ftr82 and ftr83 ancestors were already present 
before the divergence of modern groups of fishes. ftr82 and ftr83 
are part of a synteny group conserved between cypriniformes 
(zebrafish), percomorphs (medaka, stickleback, platyfish, and 
pufferfish), gadiforms (cod), and holosteans (spotted gar), 
supporting the idea that they resulted from a local duplication 
of a common ancestor that occurred prior to teleost radiation 
(Figure 1B).
FTR82 and FTR83 have the typical domain structure of 
finTRIMs, comprising a RING/B-Box/Coiled coil TRIM and a 
typical B30.2 domain (Figure 1C). Zebrafish FTR82 and FTR83 
protein sequences are 55% similar to each other (Figure  1D), 
but only 35–45% similar to other zebrafish FTRs (not shown). 
Hypervariable loops of the B30.2 domains are not highly diver-
gent between FTR82 and FTR83 (Figures 1D,E), in contrast to 
what is observed for the whole FTR group (28).
These observations indicate that ftr82 and ftr83 are “ancient” 
ftrs with structure and genomic context conserved across fishes 
and that they may have a generic function different from the main 
set of ftr, which repeatedly diversified during fish evolution.
FigUre 1 | ftr82 and ftr83, two members of the fintrim family conserved across teleost fish. (a) Neighbor joining tree including zebrafish ftr82 and ftr83, 
and their orthologs in several fish species, other fintrims, and the most similar homologs of finTRIM in fish and in human. (B) Comparison of the conserved genomic 
context of ftr82 and ftr83 genes in different fish species, as shown using the Genomicus software, with their genomic location. (c) Typical domain structure of 
finTRIMs. (D) Alignment of FTR82 and FTR83 sequences with hyper variable loops of the B30.2 domain highlighted. (e) Molecular modeling of B30.2 domains from 
FTR82 (yellow) and FTR83 (blue) derived from homology modeling based on crystal structure of huTRIM25 B30.2 domain. Visualization of models superposition was 
performed with the program Chimera.
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FigUre 2 | ftr82 and ftr83 expression pattern are distinct. (a) Spatial expression of ftr83 and ftr82 in 3.5 dpf zebrafish larvae. WISH using antisense probes 
indicated on each panel. Scale bars: 0.5 mm. (B) Genes expression in 2–3 months old juvenile zebrafish, measured by RTQPCR in various dissected tissues. 
Transcript copy numbers were normalized to β-actin expression: measured ratio of cDNA of interest/β-actin cDNA is shown. Results of three biological replicates, 
each being a pool of organs from 15 fish.
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ftr83 is Mainly expressed in Tissues 
exposed to the environment and in 
hematopoietic Tissues, while ftr82 has a 
Wider expression range
To determine the spatial pattern of expression of ftr82 and 
ftr83, we first used whole mount in situ hybridization in zebra-
fish larvae. Figure 2A shows that ftr82 and ftr83 are both well 
detectable but have distinct tissue distributions at 3.5  days 
postfertilization (dpf): while ftr82 has a relatively wide range of 
expression with high levels in the gut, ftr83 is more restricted 
to the pronephric duct and pharyngeal area, notably gill arches. 
These patterns are fully consistent with those reported in the 
public ZFIN database at the high/long-pec stage (i.e., ~2 dpf) 
[see, for ftr82, http://zfin.org/ZDB-IMAGE-021210-600 (44, 45); 
and for ftr83, http://zfin.org/ZDB-FIG-050630-7888 (45), and 
do not contradict the ftr82 pattern reported in younger embryos 
(30 hpf) by Chang et al. (39)]. In addition, they persist in the 
young adult, as shown by real time QPCR data from isolated 
organs of 3-month zebrafish (Figure  2B). At this stage, ftr83 
expression is mainly observed in gills, skin, and pharynx; it can 
also be detected in hematopoietic tissues (spleen and kidney) 
although at a much lower level. In contrast, ftr82 was well 
expressed in many tissues without clear tropism. In situ hybridi-
zation profiles also clearly indicate that in larvae, ftr82 and ftr83 
are not primarily expressed in leukocytes, which would result 
in a punctate pattern.
Strikingly, while ftr82 and ftr83 were expressed in multiple tis-
sues at a fair level, and more than other ftrs, they were not induced 
by IFN (Figure S1 in Supplementary Material).
Altogether, these data confirm that ftr82 and ftr83 do not 
constitute typical ISG, in contrast to other finTRIMs that are 
generally expressed at very low level in tissues of healthy fish and 
can be induced by viral infection and IFN (26, 35). We therefore 
hypothesized that these two conserved TRIMs expressed at 
steady-state might be involved in the natural antiviral immunity.
FTr83 affords Protection against  
rna Viruses In Vitro
To investigate whether ftr82 and ftr83 might contribute to anti-
viral defense, we assessed the impact of FTR83 (and FTR82) 
overexpression on the susceptibility to several viral infections. 
To this purpose, we first used a well-established fish cellular 
model (40). Seventy-two hours post transfection, EPC cells were 
exposed to distinct viruses (MOI1), and inhibition of viral growth 
was evaluated in titration experiments from cell supernatant up 
to three days postinfection. Figure 3A shows the effect of expres-
sion of the two HA-tagged FTRs on growth kinetics of SVCV, 
IHNV, and VSHV. FTR83 overexpression drastically inhibited 
viral growth for both IHNV and VHSV, reducing viral titers 
about 3,000-fold compared to FTR82 or to mock-transfected 
cells, at 72 hpi. The inhibition of SVCV was less efficient, but still 
highly significant with a 15 fold difference of virus titers between 
FTR83 and other conditions over the same period. The protection 
afforded by FTR83 overexpression against VHSV and IHNV was 
also observed at MOI3 (Figure S2A in Supplementary Material).
Accordingly, overexpression of FTR83 prevented viral-
induced cytotoxicity and efficiently preserved the integrity of 
the cell monolayer after infection with IHNV, VHSV, or SVCV, 
FigUre 3 | FTr83 overexpression inhibits viral infection. (a) Kinetic of viral growth measured by viral titration from 0 to 72 hpi in the supernatants of cells 
transfected with expression plasmids for ftr83 (black line) or ftr82 (gray line) or with empty vector as control (dotted line). Cells were infected at 72 hpt with IHNV, 
VSHV, or spring viremia of carp virus (SVCV) (MOI 1). The mean and SD of three independent experiments are presented. (B) Cytopathic effect of viral infections. 
Cells were infected 72 h post transfection at MOI1 and viral-induced cytopathic effect was assessed by crystal violet staining at 72 hpi. Non-infected cells are 
presented as a control (NI). (c) FTR83 triggers the IFN signaling pathway. Epithelioma papulosum cyprini cells were transfected with expression vectors for ftr82, 
ftr83 or with empty plasmid (Ctrl) and analyzed 72 h post transfection for modulation of genes of the IFN pathway: ifnϕ1, ddx58, rsad2, isg15. RTQPCR results  
were normalized on the β-actin expression: measured ratio of cDNA of interest/β-actin cDNA is shown. Mean and SD are shown, for three independent experiments; 
stars indicate significant differences using Student’s t-test (***p < 0.001, **p < 0.01, *: p < 0.05).
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as demonstrated by crystal violet colorations (Figure  3B). In 
contrast, cytopathic effect of viral infections led to the complete 
destruction of the cell monolayer at 72 hpi upon FTR82 expres-
sion or in mock-transfected conditions (Figure  3B). These 
observations were extended to non-enveloped viruses, as FTR83 
overexpression fully protected the cell monolayer against two 
strains of the birnavirus IPNV (Figure S2B in Supplementary 
Material).
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We extended our observations to other ftr fusion proteins, 
replacing HA tag by V5 or GFP for FTR82, and by GFP for FTR83, 
in N-ter or C-ter position. While all versions of FTR83 afford 
robust protection from IHNV and VHSV, none of the FTR82 
constructs showed a significant antiviral effect (Figures S2C,D 
in Supplementary Material: compare cells transfected with FT82 
plasmids with cells transfected with a control plasmid or with 
non-transfected cells), indicating that the effect did not depend 
on the tag or its position.
Altogether, these results show that FTR83—but not FTR82—
confers a potent resistance against several enveloped or non-
enveloped RNA viruses, suggesting that this TRIM triggers a 
generic antiviral mechanism.
FTr83 Promotes the expression of Key 
components of the iFn Pathway
The range of virus efficiently contained by FTR83 pointed to a 
general mechanism, possibly linked to the type I IFN response. 
We therefore studied the impact of FTR83 overexpression on 
genes involved at different levels of the IFN/PRR signaling path-
way in fish and mammals (Figure 3C), including the molecular 
sensor ddx58 (also known as rig-I); several kinases (tbk1, ralbp1 
also known as rip1, and jak1); key transcription factors as inter-
feron regulatory factors [irf3, 7, and 9; Signal Transducers and 
Activators of Transcription (stat) 1a, 1b, and 2]; type I interferon 
itself (ifnϕ1) and its receptor crfb5, as well as two ISGs: isg15 
and rsad2. TLR signaling was also investigated through adaptor 
molecules (Myd88 and ticam1).
The expression of these genes was measured by real time 
QPCR from EPC fish cells overexpressing HA-tagged FTR82 or 
FTR83 proteins 72 h post transfection. Strikingly, ifnϕ1 and the 
known ISGs rsad2, isg15, ddx58/rigI, irf7, and stat1b were sig-
nificantly upregulated upon expression of FTR83, but not FTR82, 
in absence of additional stimulation (Figure 3C; Figures S3A,B 
in Supplementary Material). Overall, these observations indicate 
that FTR83 overexpression can trigger IFNϕ1 production and 
the induction of ISGs, providing a convincing explanation for its 
antiviral activity.
a robust FTr83-Mediated Type i iFn 
induction Parallels cell Protection against 
rna Viruses, requires a Functional irF3, 
and is Observed in the context of 
infection in spite of reduced Virus load
To further connect FTR83 antiviral effect to its impact on the 
IFN pathway, we monitored the kinetics of establishment of the 
antiviral state after ftr83 transfection.
Ftr83-transfected cells were exposed to IHNV (MOI1) at 
24, 48, and 72 hpt (hours post transfection) (Figure 4A). Viral 
inhibition was then monitored by titration experiments from cell 
supernatant up to 3  days postinfection. Titration curves estab-
lished from cells exposed to virus inoculum at different times 
post transfection revealed that IHNV restriction was gradually 
established from 24 to 72 h post transfection (Figure 4A). While 
ftr83 overexpression had no significant effect on IHNV growth at 
24 h post transfection, a 2-log decrease in virus titer was observed 
48 h post transfection in ftr83 overexpressing cells, compared to 
control. This effect was even stronger 72 h post-transfection, ftr83 
triggering a 3-log reduction of virus titer. Accordingly, evaluation 
of viral-induced cytopathic effect over the same period showed a 
mild protection 48 hpt compared to control, while a full protection 
was observed 72 hpt (Figure 4B). In parallel, RTQPCR analyses 
showed increasing levels of ifnφ1 gene expression from 24 to 72 
hpt, while ftr83 level remained stable over this period (Figure 4C). 
Altogether, these results show a good correlation between type I 
IFN expression and protection against IHNV infection.
To further investigate at what level of the IFN pathway 
FTR83 was implicated, we analyzed the effect, of a dominant 
negative mutant of IRF3 (IRF3DN). This mutant consisting of 
the C-terminal domain of the protein (46) was co-expressed 
with FTR83 in EPC cells. As IRF3 is a central mediator of type 
I IFN induction, it was a good candidate to test at which level 
FTR83 activated the pathway. Of note, irf3 itself is modestly but 
significantly upregulated in cells overexpressing FTR83 (Figure 
S3B in Supplementary Material), thus enhancing its effects on 
ifn induction. The induction of ifnφ1, ddx58, and rsad2 previ-
ously observed upon FTR83 expression were abolished in cells 
overexpressing both FTR83 and IRF3DN (Figure 5A), indicating 
that FTR83 triggering of the IFN pathway occurs upstream of 
IRF3. Strikingly, the protection of the cell monolayer (Figure 5B: 
compare cells transfected with the control plasmid, with the plas-
mid encoding FTR83, and with plasmids encoding IRF3DN and 
FTR83) was abolished by the expression of IRF3DN, supporting 
the conclusion that FTR83 antiviral mechanisms depend on IRF3 
signaling and IFN induction.
Finally, our data indicate that cells overexpressing FTR83 
strongly upregulate key factors of the IFN pathway in the context 
of a viral infection. Six hours postinfection by SVCV, mRNA 
encoding the N protein of the virus was much less expressed in 
cells overexpressing FTR83, compared to the controls or to cells 
expressing FTR82 (Figure 5C, see also Figure 3A). In these con-
ditions, ifnφ1, rsad2, and ddx58 mRNAs reach about the same 
level of expression in cells expressing FTR83, as in the others 
(Figure 5C), indicating that FTR83 actually yields a robust virus-
induced type I IFN response, in spite of a reduced virus load.
ring and B30.2 Domains are required  
for the FTr83 antiviral effect
To identify the domains required for the antiviral effect, we 
constructed chimeric proteins in which the B30.2 domain had 
been exchanged between FTR83 and FTR82 as represented in 
Figure  6A. Expression of both chimeras was investigated by 
RTQPCR (Figure S4A in Supplementary Material) and immu-
nocytochemistry (Figure 6B). Similar expression was measured 
at the mRNA level for both chimeras, but distinct intracellular 
expression patterns were observed, as for wild-type FTR82 and 
FTR83: FTR83B30.2(82) shows a diffuse pattern with discrete cyto-
plasmic inclusions as for FTR83, while FTR82B30.2(83) forms large 
cytoplasmic aggregates as previously observed upon FTR82 over-
expression (Figure  6B). The subcellular distribution of FTR82 
and 83 thus seems to be mainly determined by their N-terminal 
(RBCC) domain.
FigUre 4 | antiviral effect of FTr83 is paralleled by stimulation of the type i iFn pathway. (a) Epithelioma papulosum cyprini cells were transfected with 
ftr83-encoding or empty plasmid and were infected with IHNV (MOI1) 24, 48, or 72 h post transfection. Kinetic of IHNV growth was measured by viral titration from 
0 to 72 hpi. The mean and SD of three replicates are presented. (B) Cytopathic effect of IHNV infections when cells were infected 48 and 72 h post transfection at 
MOI1. Viral-induced cytopathic effect was assessed by crystal violet staining at 72 hpi. Non-infected cells are presented as a control (NI). (c) ftr83 and ifnϕ1 
transcripts quantified by RTQPCR at the onset of infection, i.e., 24, 48, or 72 h post transfection. Results were normalized on the β-actin expression: measured  
ratio of cDNA of interest/β-actin cDNA is shown. Mean and SD of three independent experiments.
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Epithelioma papulosum cyprini cells overexpressing chime-
ras did not show upregulation of ifnϕ1, rsad2, or ddx58 genes in 
comparison with mock-transfected cells, indicating that both 
RBCC and B30.2 domains from FTR83 are required for the 
induction of the IFN pathway (Figure  6C). Accordingly, no 
decrease of the IHNV and VHSV cytopathic effect could be 
observed in cells expressing these chimeras, in contrast to FTR83 
(Figure  6D), indicating that both RBCC and B30.2 domains 
of FTR83 are required for the antiviral function as well. This 
observation was extended to SVCV infected cells (Figure S4A in 
Supplementary Material). No impact of chimeras was detected 
on the expression of the viral N transcript, which was consistent 
with a lack of antiviral activity.
We further designed FTR83 deletion mutants restricted 
to the B30.2 domain or lacking this domain. Overexpression 
of these constructs in EPC cells was not sufficient to reduce 
significantly IHNV or VHSV cytopathic effect (Figures S4C,D 
in Supplementary Material), supporting the synergistic role 
of N- and C-term part of the FTR83 protein in the antiviral 
phenotype.
Altogether, these data indicated that both RBCC and B30.2 
of FTR83 are required for innate immunity modulatory effects 
and antiviral activity, and that neither RBCC nor B30.2 can be 
substituted by corresponding domains of FTR82. In addition, we 
did not observe that FTR82 had a dominant negative effect on 
FTR83 (Figure 4B).
FTr83 Knockdown Demonstrates FTr83 
antiviral Function In Vivo
To examine whether the robust antiviral effect of FTR83 over-
expression in EPC cells discloses its natural function in vivo, we 
FigUre 5 | FTr83-mediated protection against rna viruses relies on induction of type i interferon. (a) Epithelioma papulosum cyprini cells were 
transfected with expression plasmid for ftr83, irf3DN or co-transfected (ftr83 + irf3DN). Cells transfected with empty plasmid were used as control (Ctrl). Transcripts 
of interest were quantified by RTQPCR. Five representative experiments are represented, and correspond to dotted lines (*p < 5%, Wilcoxon signed-rank test).  
(B) Transfected cells were infected by IHNV or VHSV (MOI 1) at 72 hpt, and viral-induced cytopathic effect was assessed by crystal violet staining at 72 hpi. 
Mock-transfected cells (Ctrl) and non-infected cells (NI) were used as controls. (c) Transfected cells were infected at 72 h post transfection with spring viremia of 
carp virus (SVCV) (MOI 1), and transcripts of interest were quantified by RTQPCR 6 h postinfection. Results of RTQPCR were normalized on the β-actin expression: 
measured ratio of cDNA of interest/β-actin cDNA is shown. Mean and SD are shown, for three independent experiments, and the average of induction or 
repression fold between infected and non-infected cells is shown when relevant. Stars indicate significant differences using Student’s t-test (***p < 0.001, 
**p < 0.01, *p < 0.05).
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FigUre 6 | Ftr83 domains involved in viral restriction. (a) Schematic representations of finTRIM chimeras produced by combination of FTR82 and FTR83 
domains. (B) Subcellular expression pattern of FTR83, FTR82, and chimeric proteins. HA-tagged FTR83, FTR82, and Ftr83B30.2(82) and V5-tagged Ftr82B30.2(83) were 
immunostained with relevant antibodies on transiently transfected epithelioma papulosum cyprinid (EPC) cells at 72 hpt. FTR proteins appear in red and nuclei in 
blue after DAPI staining. Scale bars: 10 µm. (c) Ifnφ1, ddx58, and rsad2 transcripts are not induced by FTR82B30.2(83) and FTR83B30.2(82) chimeras. Results of RTQPCR 
were normalized on the β-actin expression: measured ratio of cDNA of interest/β-actin cDNA is shown. Mean and SD are shown, for three independent experiments. 
(D) Cytopathic effect of novirhabdoviruses (IHNV and VHSV) on transiently transfected EPC expressing full length FTR83 (FTR83), FTR chimeras FTR83B30.2(82) or 
FTR82B30.2(83), or mock-transfected cells (Ctrl). Transfected cells were infected at MOI1 72 hpt, and viral-induced cytopathic effect was assessed by crystal violet 
staining at 72 hpi. Mock-transfected cells (Ctrl) and non-infected cells (NI) were used as controls.
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performed loss of function experiments in zebrafish embryos 
(Figure  7A). ftr83 was knocked down using a splice-blocking 
morpholino (moFTR83), which allows for a quantification of 
knockdown efficiency by qRT-PCR (Figure  7B). As shown in 
Figure  7C, moFTR83 significantly decreased the expression of 
ftr83 72hpf, compared with the control morpholino. Embryos 
were then infected i.v. with SVCV, and their RNA prepared 6 h 
later. Transcripts encoding the N protein of the virus were indeed 
FigUre 7 | Ftr83 exerts antiviral activity in vivo in zebrafish embryo. (a) Schematic drawing of the loss of function experiment in zebrafish embryos. Embryos 
were injected at the one-cell stage with 4 ng of the ftr83, ftr82 or control morpholino, injected at 72 hpi with 100 pfu of spring viremia of carp virus (SVCV), and 
analyzed 6 hpi. (B) Schematic representation of the location of splice ftr83 and ftr82 morpholinos in the respective genes (in blue). Primers allowing to distinguish 
between spliced and unspliced mRNA are shown in red. (c) The expression of ftr83, ftr82, and viral N transcripts was quantified 6 hpi by RT-PCR. Results were 
normalized on the β-actin expression. The larvae were injected with the ftr83 morpholino (MO Ftr83), with the ftr82 morpholino (MO ftr82), or with the control 
morpholino (MO Ctlr), and infected with SVCV infection or mock-infected. Data are shown relative to the expression level of the analyzed mRNA in larvae injected 
with the ftr83 morpholino (upper panels) or with the ftr82 morpholino (lower panels) and infected by SVCV (set to 1). Mean and SD are shown, for four independent 
experiments. Stars indicate significant differences using Student’s t-test (*p < 0.05).
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significantly more expressed in embryos in which ftr83 expres-
sion had been knocked down, compared to controls (Figure 7C). 
Importantly, no difference in viral replication was observed 
when FTR82 was knocked down. These results confirm that the 
antiviral activity observed in EPC cells overexpressing FTR83 is 
also observed in vivo.
In keeping with this, we also observed that expression level of 
ftr83 in gills of the adult, which is significantly variable from fish to 
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fish, shows a fair correlation with the expression of ifnφ1 (Figure 
S3C in Supplementary Material). While ftr83 was not induced by 
IFN, this correlation supported the notion that FTR83 might also 
act in vivo through the modulation of type I IFN expression in 
surfaces exposed to pathogens from the environment.
DiscUssiOn
Over the last decade, the TRIM family emerged as a subset of key 
factors involved in antiviral defense. Antiviral TRIMs have been 
involved in multiple types of mechanisms, and recent large-scale 
functional studies revealed that TRIMs are frequently modula-
tors rather than direct effectors of antiviral immunity (21, 47). 
Since TRIM proteins are also involved in many basic cellular 
functions, whether their implication in antiviral mechanisms is 
a primordial feature of the family has remained an open question.
While TRIM genes are present across metazoans, the implica-
tion in antiviral immunity of the few trim genes found in the 
genomes of basal branches of metazoans or in invertebrates (5, 23, 
24, 48) remains unknown. Interestingly, these trim mostly belong 
to the class 1 (domain structure: RBCC-COS-Fn3-B302), which 
enhances the RIG I pathway in human (21). In vertebrates, trim 
with a “RBCC-B30.2” domain structure (class 4) greatly diversi-
fied independently in several groups such as fish, crossoptery-
gians, and mammals (25, 26). In fish, several such expansions 
can be observed in available genome sequences, e.g., TRIM35, 
TRIM39 (btr), and finTRIM (ftr) in the zebrafish (26). The large 
TRIM subset named “FinTRIM”, in particular, was suspected to 
play a role in antiviral immunity: these genes were discovered 
as virus- and IFN-induced genes and constituted a large and 
diverse group, in which the B30.2 domain evolved under positive 
selection throughout the diversification (28). Such signatures of 
positive (i.e., diversifying) selection in the loop corresponding 
to the viral binding site of primate TRIM5α (36) strongly sug-
gest that they might directly bind diverse ligands, possibly viral 
epitopes. In contrast, a small subset of ftr displayed different 
features (28). They were expressed constitutively at higher levels 
compared to other ftr and were not induced by viral infection or 
type I IFN. Additionally, they were conserved across teleosts in 
contrast to the other finTRIMs genes, which apparently constitute 
independent expansions in different fish groups, for example, in 
cyprinids and salmonids. Thus, zebrafish ftr83 and ftr82 are at a 
“basal” position in the tree of ftr and likely are the closest zebrafish 
representatives of the primordial finTRIMs (28). The implication 
of these genes in immunity was therefore of particular interest 
to understand the evolution of species-specific mechanisms of 
antiviral TRIMs across vertebrates.
Our data showed that FTR83 mediates a strong antiviral activ-
ity against different RNA viruses, including enveloped and non-
enveloped viruses, supporting a primary function of basal finTRIM 
in antiviral immunity. Overexpression of FTR83 triggers the IFN 
signaling pathway, as transiently FTR83-transfected cells showed 
upregulation of type I ifn itself, as well as various ISGs: ddx58, irf7, 
irf3, stat1b, rsad2, and isg15, which mediate antiviral mechanisms 
in fish and mammals (49, 50). FTR83-based protection appar-
ently relies on the induction of IFN, since the establishment of 
an antiviral state perfectly correlated with the type IFN response. 
The transfection of a truncated dominant negative mutant of 
IRF3 was sufficient to inhibit both the FTR83-mediated antiviral 
activity and IFN induction, and that FTR83 acts upstream IRF3 
in the pathway. Importantly, in the context of a viral infection, 
FTR83 promoted the IFN response that reached the same level in 
cells overexpressing FTR83, and in controls where the infection 
had developed much more. Altogether, our data show that immu-
nomodulatory properties, a fundamental function of the TRIM 
family in mammals, are also associated to a fish finTRIM and 
represent a primordial feature of vertebrate TRIMs. Critically, the 
knockdown of ftr83 in zebrafish embryo showed that this gene is 
indeed implicated in antiviral mechanisms in vivo. These data are 
particularly interesting in the context of a series of recent reports 
of positive or negative impacts on antiviral response for a number 
of TRIM proteins from a percomorph fish, the orange spotted 
grouper (29–34, 51). The impact of multiple fish TRIM proteins 
on antiviral immunity evokes a complex array of multiple factors 
with effects at many levels of immune pathways: both conserved 
trim (e.g., trim25 or trim32) and fish-specific expansions (e.g., 
fintrim or btr) will provide beautiful models to understand the 
evolution of TRIM-mediated mechanisms.
The diversity of TRIM mechanisms and their specialization 
against different types of viruses suggested they might have site- 
or tissue-specific expression and participate to the regionalization 
of immunity. ftr83 has a restricted pattern of expression to gills, 
skin, pharynx, and to a much lesser extent hematopoietic tissues, 
as shown by ISH in the larva and by QPCR on dissected tissues in 
the adult. We also noted that the level of ftr83 expression in gills 
was highly correlated to the IFNφ1 expression in adult fish (Figure 
S3C in Supplementary Material), suggesting that ftr83 might act 
locally in areas constantly exposed to pathogens. Importantly, 
ftr83 was expressed at a higher level than other finTRIMs—that 
are generally almost undetectable in non-infected animals [(43) 
and unpublished data]—and was not induced by IFN, suggesting 
that its pattern of expression in healthy fish may reflect the regions 
in which it exerts its antiviral activity. The tissue specificity of 
ftr83 contribution to antiviral immunity would warrant further 
investigations.
The closest relative of ftr83 in the zebrafish genome is ftr82, but 
its function—which remains to be understood—is clearly very 
different: in contrast to ftr83, ftr82 overexpression did not afford 
protection of transfected cells against RNA viruses we tested and 
failed to induce any detectable IFN upregulation either upon 
basal conditions (FTR82 overexpression) or after short exposure 
of transfected cells to the RNA vesiculovirus SVCV. Indeed, a 
recent publication suggests that ftr82 plays a developmental role 
in vascular patterning (39). As ftr82 and ftr83 are closely related 
paralogs, their contrasted functional properties constituted a 
good system to investigate which domain(s) was responsible for 
the antiviral activity of FTR83 by exchanging the domains and 
making chimeric proteins. This approach has been previously 
used to demonstrate the important role of TRIM5α B30.2 domain 
to mediate antiretroviral activity (52). None of the FTR chimeras 
in which B30.2 domains had been swapped between FTR82 and 
FTR83 did afford protection against VHSV or IHNV, or modula-
tion of IFN signaling pathway. Altogether, our data indicate that 
FTR83 antiviral mechanism required both its particular RING 
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and B30.2 domains, as previously reported for several mamma-
lian TRIMs (21, 47, 53–55). While RING domain supports E3 
ubiquitin ligase activity and determines the specificity of the E2 
conjugase (56), the selection of target proteins generally occurs 
through the C-terminal domain (10). This scheme is also consist-
ent with the E3 ubiquitin ligase activity of finTRIM we showed 
previously (57).
In this work, we demonstrate that a member of the largest 
TRIM expansion, the zebrafish finTRIM, constitutes a potent 
amplifier of the type I IFN expression, and yields an antiviral activ-
ity against several viruses. It will be interesting to characterize at 
which level of the type I signaling pathway ftr83 is involved, and if it 
may also affect other pathways. This work is also a first step toward 
the immune function of ftr genes. The diversity of finTRIM, like 
the one of other fish genes involved in immunity such as ISG (43), 
complement factors (58), or heparan sulfate producing enzymes 
(59), provides many opportunities for sub-functionalization and 
will likely require systematic screening approaches.
These findings provide a framework to understand the 
repeated TRIM gene expansions during vertebrate evolution, 
and support the notion that modulation of immune pathway is a 
primordial function of TRIM proteins. Since ftr83 has orthologs 
in other fish species, including species important in aquaculture, 
our data might be useful to identify relevant markers for selection 
of fish more resistant to viral diseases.
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